Rockley Group

Founded in 2015, National Silicon Industry Group specializes in semiconductor silicon materials and the development of its ecosystem. It produces integrated circuit silicon wafers and silicon-on-insulators, with a significant production capacity.

BelGaN is a manufacturer specializing in Gallium Nitride (GaN) semiconductors. It focuses on serving the automotive, industrial, and medical sectors by producing energy-efficient semiconductor technologies.

Rockley Photonics Limited, founded in 2013 and based in London, United Kingdom, specializes in developing silicon photonics technologies for diverse applications. The company focuses on creating integrated optical modules, sensors, and comprehensive solutions that cater to high-volume and dynamic market sectors. Rockley aims to revolutionize mobile health monitoring and machine vision with its next-generation sensing platforms, while also providing high-speed solutions for data communications. By leveraging its innovative photonic integrated circuits and associated modules, Rockley is positioned to address a wide array of vertical applications, believing that photonics will become as ubiquitous as microelectronics in the future. The company combines hardware with supporting electronics, software, application algorithms, and AI platforms, establishing a robust foundation for future developments across multiple industries.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Green Biologics is a UK-based industrial biotechnology company that develops and manufactures renewable solvents and specialty chemicals through fermentation of biomass. Its portfolio includes renewable butanol, acetone, and C4 derivatives, as well as GreenFlame charcoal lighting fluids. The products support markets across paints, coatings, adhesives and inks; personal care, cosmetics and fragrances; food and flavor ingredients; health and nutrition; household and industrial cleaners; and other industrial applications. The company uses fermentation platforms to convert biomass into renewable fuels and chemicals, enabling customers to access sustainable solvents and ingredients derived from feedstocks such as corn and cellulosic materials. Operations include pilot, demo and lab facilities in the United States, with executive offices in the United Kingdom and satellite offices in China, Brazil and India. The company was incorporated in 2002 and is based in Abingdon, United Kingdom.

Kotura, Inc. specializes in silicon photonics, focusing on the design, manufacture, and marketing of CMOS optical components that facilitate the integration of optical technologies within the communications sector. The company develops silicon photonic circuits that combine optical and optoelectronic functionalities, offering application-specific integrated circuits (ASICs) tailored for various uses, including data center interconnects, computing, and telecommunications. Additionally, Kotura provides custom chip design, fabrication, and packaging services to meet the specific needs of its clients.